ZBTB4 and adrenal cortex carcinoma: In ACC, PAAD, MESO, KIRC, HNSC, KIPAN, LUAD and GBMLGG, low expression of ZBTB4 was significantly associated with shorter overall survival (Fig. 2A, D, E, F, G, H, J and L).